Can We Vaccinate Bats to Prevent the Next Pandemic?

The idea sounds improbable, even a little unsettling: vaccinating bats. But as scientists uncover more about the viruses these flying mammals carry – viruses capable of spilling over into human populations and causing devastating disease – the concept is gaining traction. A new study, published in Science Advances, offers compelling evidence that immunizing bats against viruses like rabies and Nipah could be a viable strategy to prevent future outbreaks, and researchers are exploring innovative delivery methods, including genetically engineered mosquitoes and oral vaccines.

The Role of Bats in Viral Spillover

Bats are reservoirs for a surprising number of viruses that can cause severe illness in humans. These include Ebola, Nipah, Hendra, and various coronaviruses, as well as the ever-present threat of rabies. Research on bat immunity highlights their unique ability to harbor these pathogens without succumbing to illness, a phenomenon linked to their robust immune systems. However, this tolerance doesn’t prevent them from transmitting viruses to other animals – and to people. When these viruses jump species, the consequences can be dire, as seen with past outbreaks of Nipah and Ebola.

Historically, responses to bat-borne viruses have often involved culling bat populations. However, Aihua Zheng, a virologist at the Chinese Academy of Sciences, points out the counterproductive nature of this approach. “When people kill the bats, basically they have more contact with the bat,” Zheng explains. “There are more chances to get infected.” bats play crucial ecological roles, including pollination and insect control, and are already facing threats from habitat loss and disease.

A Novel Approach: Vaccinating the Reservoir

Zheng and his team propose a different solution: proactively vaccinating bats against the viruses they carry. This approach, detailed in their recent publication, aims to reduce viral shedding and transmission, protecting both human and animal populations. The challenge, of course, lies in the logistics of vaccinating a wild animal population that flies and roosts in often inaccessible locations.

The researchers explored two primary methods. One involved adapting a technique used in previous studies where a topical vaccine was applied to bat fur, relying on social grooming to spread the vaccine. While effective in the lab, Zheng notes the difficulty of scaling this method for widespread application. “You have to catch a lot of bats and then release them,” he says.

The Mosquito Vector Strategy

Their more innovative approach involved using mosquitoes as tiny, flying syringes. The team genetically engineered mosquitoes to carry vaccines against Nipah and rabies viruses in their saliva. The idea is that when these mosquitoes bite bats, or are consumed by them (insectivorous bats are common), they deliver the vaccine. Experiments with mice and rodents showed promising results, and subsequent tests with bats captured from the suburbs of Beijing confirmed the bats developed antibodies after exposure to the vaccinated mosquitoes. Importantly, bats that received the vaccine showed increased survival rates when later infected with the rabies virus.

Zheng envisions a future where modified mosquitoes are released into caves, utilizing airflow to trap the insects inside while allowing bats to approach and go freely, gradually immunizing the population. While ambitious, this strategy offers a potentially scalable solution.

Oral Vaccination as a Backup Plan

Recognizing that the mosquito-based approach may not be feasible in all environments, the researchers also developed an oral vaccine. They found that bats readily consumed a saline solution containing a rabies vaccine. This method also proved effective in generating an immune response and protecting against subsequent infection. “Yeah, it really worked!” Zheng exclaims. “I’m pretty excited with these results.”

Expert Perspectives and Next Steps

The research has garnered attention from experts in the field. Ausraful Islam, a veterinarian and infectious disease specialist at icddr,b in Bangladesh, calls the study “amazing,” noting its potential benefits for countries grappling with bat-borne viruses. However, he also emphasizes the need for further research, particularly regarding the duration of immunity and the feasibility of large-scale vaccination campaigns. Recent research also highlights the emergence of bat viruses resistant to existing vaccines, underscoring the importance of proactive measures like vaccination.

Zheng and his team are now planning further studies and seeking international collaborations to refine their techniques and assess the long-term efficacy of bat vaccination. The process of translating these findings into real-world applications will involve careful consideration of ecological factors, regulatory hurdles, and public acceptance. The next phase will likely involve more extensive field trials to evaluate the effectiveness of these methods in natural bat populations and to monitor for any unintended consequences. Ongoing surveillance of bat viruses and human exposure will also be crucial to inform vaccination strategies and assess their impact.

This research represents a significant shift in thinking about how to prevent bat-borne diseases, moving away from reactive culling and towards a proactive, preventative approach. While challenges remain, the prospect of vaccinating bats to protect both animal and human health offers a glimmer of hope in the ongoing battle against emerging infectious diseases.